Back to Stakeholders

Morgan Stanley is tracked as an institutional-capital stakeholder relevant to financing exposure in psychedelic and adjacent mental-health sectors.

Investor Snapshot

Institutional Investors

Classification

Institutional Investor

Geography

Global

Coverage

Global

Last Verified

Apr 9, 2026

Investment Stage Focus

Growth / Late StagePublic MarketsMulti-Stage

Investment Focus Areas

Drug Development

Investor Notes

Added from user-provided legacy investor list and retained with cross-tag-safe categorization. Explicit psychedelic relevance is captured from listed source evidence.

Verification

Unverified

Psychedelic Focus

No Public Psychedelic Focus

Engagement Status

Active

Primary Investment Link

Quick Facts

Website
Visit